EDN1 and COVID-19: In the present study, we also found increased systemic arterial and central venous ET-1 levels in COVID-19-induced ARDS, further supporting the notion that it may be involved in the pathophysiology of severe COVID-19, consistent with its role as a potent vasoconstrictor and mediator of inflammation.